Hemoglobin levels during radiation therapy and their influence on local control and survival of patients with endometrial carcinoma

Oncology Reports

Volumn 11, Issue 3, 2004, Pages 711-717

  Münstedt, Karsten ^a   Völzing, Margrit ^a   Von Georgi, Richard ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Endometrial cancer; Hemoglobin; Prognosis; Radiotherapy

Indexed keywords

HEMOGLOBIN;

AGED; ARTICLE; BIOSYNTHESIS; BLOOD; DISEASE FREE SURVIVAL; ENDOMETRIUM TUMOR; FEMALE; HUMAN; MIDDLE AGED; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HEMOGLOBINS; HUMANS; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 4644320229     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.3.711     Document Type: Article

References (32)

1. Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, Itri LM, Johnson DH, Scherr SL and Portency RK: Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. Semin Hematol 34: 4-12, 1997.
2. Cella D: Factors influencing quality of life in cancer patients: anemia and fatigue. Semin Oncol 25 (Suppl. 7): 43-46, 1998.
3. Coiffier B: The impact and management of anaemia in haematological malignancies. Med Oncol 17 (Suppl. 1): S2-S10, 2000.
4. Ludwig H and Fritz E: Anemia in cancer patients. Semin Oncol 25 (Suppl. 7): 2-6, 1998.
5. Caro JJ, Salas M, Ward A and Goss G: Anemia as an independent prognostic factor for survival in patients with cancer: a systematic, quantitative review. Cancer 91: 2214-2221, 2001.
6. Jatzko GR, Lisborg PH, Denk H, Klimpfinger M and Stettner HM: A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. Cancer 76: 1302-1312, 1995.
7. Obermair A, Cheuk R, Horwood K, Janda M, Bachtiary B, Schwanzellberger B, Stoiber A, Nicklin JL, Perrin LC and Crandon AJ: Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma: preliminary results. Cancer 92: 903-908, 2001.
8. Pollack A, Zagars GK, Dinney CP, Swanson DA and von Eschenbach AC: Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients. Cancer 74: 2819-2827, 1994.
9. Dunphy EP, Petersen IA, Cox RS and Bagshaw MA: The influence of initial hemoglobin and blood pressure levels on results of radiation therapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 16: 1173-1178, 1989.
10. Wagner W, Hermann R, Hartlapp J, Esser E, Christoph B, Muller MK, Krech R and Koch O: Prognostic value of hemoglobin concentrations in patients with advanced head and neck cancer treated with combined radio-chemotherapy and surgery. Strahlenther Onkol 176: 73-80, 2000.
11. Lee WR, Berkey B, Marcial V, Fu KK, Cooper JS, Vikram B, Coia LR, Rotman M and Ortiz H: Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 42: 1069-1075, 1998.
12. Glaser CM, Millesi W, Kornek GV, Lang S, Schull B, Watzinger F, Selzer E and Lavey RS: Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 50: 705-715, 2001.
13. Fein DA, Lee WR, Hanlon AL, Ridge JA, Langer CJ, Curran WJ and Coia LR: Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol 13: 2077-2083, 1995.
14. Obermair A, Handisurya A, Kaider A, Sevelda P, Kolbl H and Gitsch G: The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients: a prospective review. Cancer 83: 726-731, 1998.
15. Okunieff P, De Bie J, Dunphy EP, Terris DJ and Höckel M: Oxygen distributions partly explain the radiation response of human squamous cell carcinomas. Br J Cancer Suppl 27: S185-S190, 1996.
16. Vaupel P, Thews O and Höckel M: Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol 18: 243-259, 2001.
17. Kumar P: Tumor hypoxia and anemia: impact on the efficacy of radiotherapy. Semin Hematol 37 (Suppl. 6): 4-8, 2000.
18. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW and Giaccia AJ: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379: 88-91, 1996.
19. National Cancer Institute Cancer Therapy Evaluation Program: Common toxicity criteria manual, v. 2.0, 1999. Available at: http://ctep.cancer.gov/ reporting/ctc.html. Accessed September 13, 2002.
20. Vahrson H: Die Strahlentherapie des Korpuskarzinoms. In: Giessener Gynäkologische Fortbil dung 1991. Kunzel W and Kirschbaum M (eds.) Springer, Berlin, Heidelberg, pp163-179, 1991.
21. Look K: Stage I-II endometrial adenocarcinoma evolution of therapeutic paradigms: the role of surgery and adjuvant radiation. Int J Gynecol Cancer 12: 237-249, 2002.
22. Brumm C, Fasching PA and Beckmann MW; Therapieentscheidungen beim Endometriumkarzinom nach Levels of Evidence und Grades for Recommendation. Zentralbl Gynakol 124: 32-35, 2002.
23. Benson K and Hartz AJ: A comparison of observational studies and randomized, controlled trials. N Engl J Med 342: 1878-1886, 2000.
24. Grogan M, Thomas GM, Melamed I, Wong FL, Pearcey RG, Joseph PK, Portclance L, Crook J and Jones KD: The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 86: 1528-1536, 1999.
25. Littlewood TJ, Bajetta E, Nortier JW, Vercammen E and Rapoport B: Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving non-platinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 19: 2865-2874, 2001.
26. Nowrousian MR: Classification and characterization of anemia in cancer. In: Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Nowrousian MR (ed.) Springer, Wien, New York, pp23-38, 2002.
27. Henry DH: Changing patterns of care in the management of anemia. Semin Oncol 19 (Suppl. 8): 3-7, 1992.
28. Jain R: Use of blood transfusion in management of anemia. Med Clin North Am76: 727-744, 1992.
29. Hyung WJ, Noh SH, Shin DW, Huh J, Huh BJ, Choi SH and Min JS: Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer. Ann Surg Oncol 9: 5-12, 2002.
30. Murata N, Idezuki Y, Konishi T, Watanabe H, Ushirokoji Y, Shinohara K, Shibusawa M, Haga S, Hiraishi M, Bandai Y, Yamamura T, Yumoto S, Gunji A and Nishigaki K: Influence of perioperative blood transfusion on the prognosis of patients with gastric cancer receiving anticancer chemotherapy. Gastric Cancer 3: 24-27, 2000.
31. Mittelman M, Neumann D, Peled A, Kanter P and Haran-Ghera N: Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models. Proc Natl Acad Sci USA 98: 5181-5186, 2001.
32. Cremieux PY, Barrett B, Anderson K and Slavin MB: Cost of outpatient blood transfusion in cancer patients. J Clin Oncol 18: 2755-2761, 2000.